Evidence map›Paper›PMID 26877262›Full record

ArticleThe American journal of pathology2016

Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma.

Shokoufeh Shahrabi-Farahani, Marina Gallottini, Fabiana Martins, Erik Li, Dayna R Mudge, Hironao Nakayama, Kyoko Hida, Dipak Panigrahy, Patricia A D'Amore, Diane R Bielenberg

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Shokoufeh Shahrabi-FarahaniVascular Biology Program, Boston Children's Hospital, Boston, Massachusetts.
Marina GallottiniDepartment of Stomatology, Dental School of the University of Sao Paulo, Brazil.
Fabiana MartinsDepartment of Stomatology, Dental School of the University of Sao Paulo, Brazil.
Erik LiVascular Biology Program, Boston Children's Hospital, Boston, Massachusetts.
Dayna R MudgeCenter for Vascular Biology Research, Beth Israel Deaconess Hospital, Boston, Massachusetts.
Hironao NakayamaVascular Biology Program, Boston Children's Hospital, Boston, Massachusetts; Department of Surgery, Harvard Medical School, Boston, Massachusetts.
Kyoko HidaVascular Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Dipak PanigrahyCenter for Vascular Biology Research, Beth Israel Deaconess Hospital, Boston, Massachusetts; Department of Pathology, Harvard Medical School, Boston, Massachusetts.
Patricia A D'AmoreDepartment of Opthalmology, Harvard Medical School, Boston, Massachusetts; Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.
Diane R BielenbergVascular Biology Program, Boston Children's Hospital, Boston, Massachusetts; Department of Surgery, Harvard Medical School, Boston, Massachusetts. Electronic address: diane.bielenberg@childrens.harvard.edu.
Boston Children's Hospital · USUniversidade de São Paulo · BRBeth Israel Deaconess Hospital · USBeth Israel Deaconess Medical Center · USHokkaido University · JPMassachusetts Eye and Ear Infirmary · US

Funding

Pilot and Feasibility Project ProgramP30GM103331 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KERN, MICHAEL J · 2012 to 2016
$5.2M
Role of RPE-derived VEGF in Choroid Development and StabilityR01EY015435 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI D'AMORE, PATRICIA ANN · 2004 to 2013
$4.3M
Control of cancer and metastasis by endothelial-derived epoxyeicosatrienoic acidsR01CA148633 · NCI · BOSTON CHILDREN'S HOSPITAL · PI PANIGRAHY, DIPAK · 2010 to 2014
$1.4M
Semaphorin 3F: Structure, Function, and Anti-Metastatic ActivityK01CA118732 · NCI · BOSTON CHILDREN'S HOSPITAL · PI BIELENBERG, DIANE RENEE · 2006 to 2010
$774k
Targeting Neuropilin 2 with Semaphorin 3F during Pancreatic Carcinoma ProgressionR21CA155728 · NCI · BOSTON CHILDREN'S HOSPITAL · PI BIELENBERG, DIANE RENEE · 2011 to 2012
$416k
NCI NIH HHS K01 CA118732NCI NIH HHS K01CA118732NCI NIH HHS R01 CA148633NCI NIH HHS R01CA148633NCI NIH HHS R21 CA155728NCI NIH HHS R21CA155728NEI NIH HHS R01 EY015435NEI NIH HHS R01EY015435NIGMS NIH HHS P30 GM103331NIGMS NIH HHS P30GM103331
6 · The paper itself

Abstract

Neuropilins are receptors for disparate ligands, including proangiogenic factors such as vascular endothelial growth factor and inhibitory class 3 semaphorin (SEMA3) family members. Differentiated cells in skin epithelium and cutaneous squamous cell carcinoma highly express the neuropilin-1 (NRP1) receptor. We examined the expression of NRP1 in human and mouse oral mucosa. NRP1 was significantly up-regulated in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC). NRP1 receptor localized to the outer suprabasal epithelial layers in normal tongue, an expression pattern similar to the normal skin epidermis. However, dysplastic tongue epithelium and OSCC up-regulated NRP1 in basal and proliferating epithelial layers, a profile unseen in cutaneous squamous cell carcinoma. NRP1 up-regulation is observed in a mouse carcinogen-induced OSCC model and in human tongue OSCC biopsies. Human OSCC cell lines express NRP1 protein in vitro and in mouse tongue xenografts. Sites of capillary infiltration into orthotopic OSCC tumors correlate with high NRP1 expression. HSC3 xenografts, which express the highest NRP1 levels of the cell lines examined, showed massive intratumoral lymphangiogenesis. SEMA3A inhibited OSCC cell migration, suggesting that the NRP1 receptor was bioactive in OSCC. In conclusion, NRP1 is regulated in the oral epithelium and is selectively up-regulated during epithelial dysplasia. NRP1 may function as a reservoir to sequester proangiogenic ligands within the neoplastic compartment, thereby recruiting neovessels toward tumor cells.

Indexed as

Carcinoma in SituCarcinoma, Squamous CellCell DifferentiationEpitheliumHumansMaleMiddle AgedMouth NeoplasmsReceptors, Neurokinin-1Skin NeoplasmsUp-RegulationReceptors, Neurokinin-1

Identifiers

PMID26877262
PMCPMC4822338
OpenAlexW2267639857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.